Company and Vaccine or Product

Date of License

Date of Revocation

Pfizer Ltd.a

 

 

Poliovirus, live, oral trivalent

10/28/1966

06/17/1979

Poliovirus, oral type 1

08/17/1961

06/12/1979

Poliovirus, oral type 2

10/06/1961

06/12/1979

Poliovirus, oral type 3

03/27/1962

06/12/1979

Praxis Biologics, Incorporatedd

 

 

Haemophilus b conjugate vaccine (diphtheria CRM197 protein conjugate)

12/21/1988

 

Haemophilus b polysaccharide vaccine

04/12/1985

 

Research Foundation for Microbial Diseases, Osaka University

 

 

Acellular pertussis vaccine concentrate

08/20/1992

 

Japanese encephalitis virus vaccine inactivated

12/10/1992

 

SCLAVO s.p.a.f

 

 

Cholera

08/19/1976

 

Diphtheria and tetanus toxoids and pertussis vaccine adsorbed

03/31/1978

 

Diphtheria toxoid

01/04/1963

 

DT, adsorbed

03/31/1978

 

Tetanus toxoid

01/04/1963

 

Tetanus toxoid, adsorbed

08/05/1970

 

Tetanus & diphtheria toxoids adsorbed (for adult use)

02/16/1979

 

SmithKline Beechame

 

 

Hepatitis B, recombinant

08/28/1989

 

Rubella virus, live

03/12/1970

10/05/1982

Swiss Serum Institute

 

 

Tetanus toxoid, adsorbed

12/11/1970

 

Typhoid vaccine, oral, Ty21a

12/15/1989

 

Takeda Chemical Industries, Ltd.,

 

 

Acellular pertussis vaccine concentrate (for further manufacturing)

12/17/1991

 

Texas Department of Health Resources

 

 

Diphtheria & tetanus toxoids & pertussis vaccine adsorbed

07/27/1970

02/06/1979

Diphtheria toxoid

01/06/1963

02/06/1979

DT, adsorbed

07/27/1970

02/06/1979

Pertussis

12/27/1954

02/06/1979



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement